Sign Out
Hypersensitivity to filgrastim, Escherichia coli-derived proteins or any component of the product.
To increase the dose of cytotoxic chemotherapy beyond established dosage regimens.
Severe congenital neutropenia (Kostmann's syndrome) with abnormal cytogenetics (see Precautions).
Continue with Google